Parallel Advisors’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $131 | Hold |
49
| – | – | ﹤0.01% | 3419 |
|
|
2025
Q1 | $393 | Sell |
49
-1
| -2% | -$8 | ﹤0.01% | 3261 |
|
|
2024
Q4 | $481 | Hold |
50
| – | – | ﹤0.01% | 3206 |
|
|
2024
Q3 | $926 | Hold |
50
| – | – | ﹤0.01% | 3040 |
|
|
2024
Q2 | $828 | Hold |
50
| – | – | ﹤0.01% | 2988 |
|
|
2024
Q1 | $864 | Hold |
50
| – | – | ﹤0.01% | 2964 |
|
|
2023
Q4 | $778 | Hold |
50
| – | – | ﹤0.01% | 2992 |
|
|
2023
Q3 | $2.46K | Hold |
50
| – | – | ﹤0.01% | 2750 |
|
|
2023
Q2 | $3.89K | Hold |
50
| – | – | ﹤0.01% | 2525 |
|
|
2023
Q1 | $4.51K | Hold |
50
| – | – | ﹤0.01% | 2446 |
|
|
2022
Q4 | $5.87K | Sell |
50
-6
| -11% | -$705 | ﹤0.01% | 2261 |
|
|
2022
Q3 | $10K | Buy |
56
+6
| +12% | +$1.07K | ﹤0.01% | 1992 |
|
|
2022
Q2 | $4K | Hold |
50
| – | – | ﹤0.01% | 2377 |
|
|
2022
Q1 | $8K | Buy |
+50
| New | +$8K | ﹤0.01% | 2127 |
|